Experimental Celiac Drug Reduced Gluten-Triggered Intestinal Damage in Early Trial
An experimental immune-targeting treatment reduced intestinal damage during six weeks of gluten exposure in a small randomized study of adults with celiac disease.
Latest Developments
Home